S-EPMC11999879 - Targeting ferroptosis resistance resensitizes metastatic HR<sup>+</sup>HER2<sup>-</sup> breast cancer cells to palbociclib-hormone therapy. - OmicsDI

Unknown

Dataset Information

Targeting ferroptosis resistance resensitizes metastatic HR<sup>+</sup>HER2<sup>-</sup> breast cancer cells to palbociclib-hormone therapy.

ABSTRACT:

SUBMITTER: Pottier C

PROVIDER: S-EPMC11999879 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature